NCT00944385已完成4 期
Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
According to TEG (thromboelastography), as maximum amplitude is increased the amount of bleeding and transfusion and Cardiac enzyme is reduced by using ulinastatin.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •40% below of output of left ventricle
- •tricuspid valve failure from moderate to severe
- •urgent surgery required
- •infectious endocarditis
排除标准
- 未提供
研究组 & 干预措施
ulinastatin
Experimental
Administer with 30,000U /ulinastatin
干预措施: ulinastatin (Drug)
C group
Placebo Comparator
administer normal saline
干预措施: ulinastatin (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Pleiotropism of Statin Therapy in High Dose Versus Low Dose Combined With EzetimibeEndothelial FunctionNCT01241097Federal University of Bahia60
已完成
不适用
The Multicenter Atorvastatin Plaque Stabilization (MAPS) StudySymptomatic Carotid StenosisIndication for Carotid EndarterectomyHypercholesterolemiaNCT01053065University of Padova60
Unknown
3 期
Effects of High Dose Atorvastatin in Patients With Surgical Aortic StenosisAortic Valve StenosisVentricular HypertrophyNCT00811330University Hospital, Strasbourg, France60
Unknown
3 期
Sitagliptin and Endothelial DysfunctionHealthyNCT02406950Kyunghee University Medical Center10
进行中（未招募）
不适用
EFFECTS OF STATIN POTENCY ON MAJOR CARDIOVASCULAR EVENTS IN ACUTE ST ELEVATION MYOCARDIUM INFARCTION PATIENTS.ST elevation myocardium infarctionprimary percutaneous coronary interventionStatin intensitysecondary preventioncardiovascular outcomeTCTR20180502001none900